Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06414_DB08919_nanopub.RAGeGSvaQfPR60lZW12_wKdsClKNR2McAvYPL1jqGL8CU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06414_DB08919 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08919 label "DDI between Etravirine and Zuclopenthixol acetate - Zuclopenthixol (especially oral dosage form) may experience a decrease in serum concentration when used concomitantly with etravirine. It is recommended to monitor zuclopenthixol therapy for efficacy. [drugbank_resource:DB06414_DB08919]" assertion.
- drugbank_resource:DB06414_DB08919 identifier "drugbank_resource:DB06414_DB08919" assertion.
- drugbank_resource:DB06414_DB08919 title "DDI between Etravirine and Zuclopenthixol acetate - Zuclopenthixol (especially oral dosage form) may experience a decrease in serum concentration when used concomitantly with etravirine. It is recommended to monitor zuclopenthixol therapy for efficacy." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08919 assertion.
- drugbank:DB08919 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08919 assertion.